You have 9 free searches left this month | to do more

Nilotinib

Nilotinib is a drug used to treat Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumors, Leukemia, and other conditions. Nilotinib is being actively studied in 28 studies and prior, has been studied in 57.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative SiteAndrew J. Wagner, MD, PhD
Gruppo Italiano Malattie EMatologiche dell'AdultoComplesso Ospedaliero S. Giovanni AddolorataChul Won Jung
M.D. Anderson Cancer CenterDipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli"David Miklos
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
  • Chordoma
  • Nilotinib
  • Radiation therapy
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-10-27
Oct 27, 2021
N
Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • nilotinib
  • Nagoya, Aichi, Japan
  • +10 more
2021-05-17
May 17, 2021
S
Completed
  • Ataxia, Cerebellar
  • Ataxia, Progressive
  • Nilotinib
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2021-09-23
Sep 23, 2021
W
Completed
  • Chronic Myeloid Leukemia
  • Nilotinib
  • New York, New York
    Weill Cornell Medical College
2022-01-04
Jan 4, 2022
N
Not yet recruiting
  • Peritoneal Carcinomatosis
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-18
Jan 18, 2022
A
Recruiting
  • Chronic Myelogenous Leukemia
  • Nilotinib
  • Beirut, Lebanon
    American University of Beirut Medical Center
2021-01-11
Jan 11, 2021
S
Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Nilotinib
  • Nilotinib
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
2020-11-11
Nov 11, 2020
H
Completed
  • Chronic Phase Chronic Myeloid Leukemia
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-01-04
Jan 4, 2021
N
Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • HUS, Finland
  • +6 more
2021-04-13
Apr 13, 2021
U
Withdrawn
  • Leukemia, Chronic Myeloid
  • Ann Arbor, Michigan
  • +1 more
2021-02-11
Feb 11, 2021
N
Terminated
  • CML
  • +2 more
  • nilotinib
  • Las Vegas, Nevada
  • +2 more
2021-04-28
Apr 28, 2021
A
Active, not recruiting
  • Pigmented Villonodular Synovitis
  • +2 more
  • nilotinib
  • Santa Monica, California
  • +6 more
2021-05-20
May 20, 2021
O
Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • Nilotinib
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-03-19
Mar 19, 2021
N
Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Nilotinib
  • Tokyo, Japan
    Novartis Investigative Site
2020-12-06
Dec 6, 2020
A
Completed
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • Seoul, Korea, Republic of
    Asan Medical Center
2020-01-06
Jan 6, 2020
G
Completed
  • Chronic Graft Versus Host Disease
  • nilotinib
  • Tel Hashomer, Israel
  • +11 more
2021-08-19
Aug 19, 2021
E
Active, not recruiting
  • Chronic Myeloid Leukemia
  • TKI discontinuation
  • nilotinib
  • Freiburg, Baden-Württemberg, Germany
  • +14 more
2021-11-04
Nov 4, 2021
N
No longer available
  • Hypereosinophilic Syndrome (HES)
  • Nilotinib
  • (no location specified)
2021-09-14
Sep 14, 2021
M
Completed
  • Untreated Adult Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +1 more
2020-08-04
Aug 4, 2020
S
Completed
  • Bone Marrow Transplant Failure
  • +2 more
  • Nilotinib
  • Stanford, California
  • +4 more
2020-04-13
Apr 13, 2020